The increasing prevalence of targeted diseases is anticipated to create market opportunities for market players. In Sweden, the median age of menopause is 51 to 52 years and around 65,000 Swedish women reach menopause every year. Medical conditions associated with menopause such as hot flushes and night sweat increased the demand for medicinal products to manage these symptoms.
According to the European Journal of Contraception & Reproductive Health Care survey published in August 2022, around 62.4% of the total 1,016 Swedish women participants currently used contraception, and unmet need for contraception has increased to 17.2%.
Global players enter into strategic partnerships with local players to enhance their presence in the country, thereby gaining a high market share. Companies are involved in the introduction of novel therapeutic drugs for fertility, menopause, and other women’s health applications.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account